dopamine agents

Preferred Label : dopamine agents;

MeSH definition : Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.;

MeSH synonym : agents, dopaminergic; agents, dopamine; dopaminergic drugs; drugs, dopaminergic; dopamine drugs; drugs, dopamine; dopaminergic agents;

Related MeSH term : dopamine effect; Effect, Dopamine; Dopaminergic Effect; Effect, Dopaminergic; Dopaminergic Effects; Effects, Dopaminergic; Dopamine Effects; Effects, Dopamine;

MeSH annotation : general or unspecified; prefer specifics; note entry term DOPAMINE EFFECT: use only for the dopamine effect of a chemical substance;

Wikipedia link : https://en.wikipedia.org/wiki/Dopamine agents;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D015259;

UMLS CUI

C0013036;

ATC code(s)
- dopaminergic agents [ATC Code]
- levodopa [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Dopamine Agonist [NCIt concept]
- Dopamine Hydrochloride [NCIt concept]
- Dopaminergic agents [ICD-11 Extension code]
Record concept(s)
- dopamine agents [MeSH concept]
- dopamine effect [MeSH concept]
See also
- dopamine [MeSH Descriptor]
See also inter- (CISMeF)
- DOPamine [LOINC component]
- Dopamine [NCIt concept]
- Dopamine [FMA entity]
- Dopamine (substance) [SNOMED CT concept]
- dopamine [SNOMED Notion]
- dopamine [Substance BNPC]
- dopamine [ATC Code]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine [MeSH Descriptor]
- BAK4-54 [MeSH Supplementary Concept]
- CAB2-015 [MeSH Supplementary Concept]
- CE-123 [MeSH Supplementary Concept]
- Dexpramipexole [MeSH Descriptor]
- Duloxetine Hydrochloride [MeSH Descriptor]
- amantadine [MeSH Descriptor]
- benserazide [MeSH Descriptor]
- benserazide, levodopa drug combination [MeSH Supplementary Concept]
- carbidopa [MeSH Descriptor]
- dihydroxyphenylalanine [MeSH Descriptor]
- dopamine [MeSH Descriptor]
- fusaric acid [MeSH Descriptor]
- levodopa [MeSH Descriptor]
- memantine [MeSH Descriptor]
UMLS correspondences (same concept)
- dopaminergic agents [ATC Code]
Validated automatic mappings to BTNT
- dopaminergic agents [ATC Code]
- other dopaminergic agents [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients